Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLNR.L Regulatory News (CLNR)

  • There is currently no data for CLNR

Grant of Options

16 Jun 2020 07:00

RNS Number : 0334Q
Cluff Natural Resources plc
16 June 2020
 

Cluff Natural Resources Plc / Index: AIM / Epic: CLNR / Sector: Natural Resources

16 June 2020

Cluff Natural Resources Plc ('CLNR', 'Cluff' or 'the Company')

Grant of Options

Cluff Natural Resources Plc, the AIM-quoted natural resources investing company with a high impact exploration and appraisal portfolio focused on the Southern and Central North Sea, announces that on 15 June 2020, the Company granted options ("Options") over a total of 6,532,258 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares"). As part of this grant, 5,032,258 Options have been awarded to Sarah McLeod, Chief Financial Officer of the Company, a person discharging managerial responsibilities (PDMR).

 

The Options have been granted pursuant to entitlements associated with employment contracts and have an exercise price of 1.55 pence, being the closing mid-market price of the Company's Ordinary Shares on 6 January 2020, the date of Sarah McLeod's appointment as Chief Financial Officer. The exercise price represents a premium of 128% to the closing mid-market price of the Company's Ordinary Shares on 15 June 2020. The Options have been granted pursuant to the Company's Enterprise Management Incentives Plan and are subject to certain performance criteria as detailed below.

 

The Options may vest in three equal tranches over three years, subject to meeting certain share price performance criteria and are exercisable, to the extent vested, until 10 years from the date of grant. The first tranche of one third of the Options may vest after one year, subject to the Company's share price increasing by at least 33% over the exercise price and remaining at or above that level for at least 30 consecutive days. The second tranche of one third of the Options may vest after two years, subject to the Company's share price increasing by at least 66% over the exercise price and remaining at or above that level for at least 30 consecutive days. The third and final tranche may vest after three years, subject to the Company's share price increasing by at least 100% over the exercise price and remaining at or above that level for at least 30 consecutive days. Following vesting, the Options are subject to a further two-year retention period before they may be exercised. 

 

The 6,532,258 Options subject to this grant are equivalent to 0.46% of the Company's current issued share capital. In total 94,840,450 Options are now outstanding, representing approximately 6.75% of the Company's current issued share capital. The total number of Ordinary Shares currently in issue is 1,405,964,855. The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sarah McLeod

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cluff Natural Resources Plc

b)

LEI

213800TS8K1D27AFP275

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 Grant of options over ordinary shares of 0.5p

 

Identification code

ISIN: GB00B6SYKF01

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1.55 pence per share

5,032,258

d)

Aggregated information:

- Aggregated volume

- Price

n/a

e)

Date of the transaction

15 June 2020

f)

Place of the transaction

Outside a trading venue

 

 

**ENDS**

 

For further information please contact the following:

 

Cluff Natural Resources Plc

Tel: +44 (0) 20 7887 2630 

Graham Swindells / Andrew Nunn/ Sarah McLeod 

 

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

Tel: +44 (0) 20 3328 5656

David Hart / Alex Brearley / Asha Chotai (Corporate Finance)

 

 

Stifel Nicolaus Europe Limited (Joint Broker)

 

Tel: +44 (0) 20 7710 7600

Callum Stewart / Simon Mensley / Ashton Clanfield

 

 

Capital Markets Communications Ltd ('Camarco') (PR & IR)

 

Tel: +44 (0) 20 3757 4983

Billy Clegg / James Crothers / Julia Tilley (Financial PR)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFFFFIRAIELII
Date   Source Headline
16th Jun 20207:00 amRNSGrant of Options
8th Jun 20207:00 amRNSHolding(s) in Company
4th Jun 202012:30 pmRNSResult of Annual General Meeting
4th Jun 20207:00 amRNSAGM Statement, Operational and Corporate Update
29th May 20207:00 amRNSChange of registered address
21st May 20205:39 pmRNSHolding(s) in Company
13th May 20207:00 amRNSNotice of Annual General Meeting
24th Apr 20207:00 amRNSPosting of Annual Report and Accounts
21st Apr 20207:00 amRNSDirector/PDMR Shareholdings
16th Apr 20207:00 amRNSFinal Results
13th Mar 20207:00 amRNSUpdate Following Oil Price Volatility
17th Feb 202012:45 pmRNSHolding(s) in Company
8th Jan 20207:00 amRNSAppointment of Chief Financial Officer
3rd Dec 20193:41 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSOperational and Licence Update
16th Sep 20197:00 amRNSInterim Results
22nd Aug 20197:00 amRNSOperations Update - Licence P2252
13th Aug 20197:00 amRNSCompletion of Farm-out of Licence to Shell U.K.
5th Aug 20197:00 amRNSOperations Update - Licence P2252
31st Jul 20197:00 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSHolding(s) in Company
9th Jul 20197:00 amRNSGrant of share options to Executive Directors
5th Jul 20197:00 amRNSAppointment of Joint Broker
3rd Jul 20197:00 amRNSHolding(s) in Company
2nd Jul 201911:51 amRNSHolding(s) in Company
1st Jul 20191:15 pmRNSHolding(s) in Company
1st Jul 20197:00 amRNSDewar Prospect Commercial Feasibility Study
27th Jun 20195:00 pmRNSReplacement: Result of GM - Revised Admission Date
25th Jun 20194:00 pmRNSResult of GM - Revised Admission Date 1 July 2019
6th Jun 20197:00 amRNSResults of Placing and Subscription
5th Jun 20194:45 pmRNSProposed Fundraising to Raise a Minimum £15million
30th May 20197:00 amRNSCompletion of Farm on Licences P2252 to Shell
22nd May 20194:14 pmRNSResult of AGM
30th Apr 201910:08 amRNSShell U.K. Limited Exercises Option on P2437
29th Apr 20194:00 pmRNSPosting of Annual Report and Notice of AGM
25th Apr 20197:00 amRNSPreliminary Results
12th Apr 20197:00 amRNSBoard Change
28th Feb 20195:00 pmRNSTotal Voting Rights
15th Feb 201911:41 amRNSHolding(s) in Company
13th Feb 20197:00 amRNSExercise of options and sale of shares by director
8th Feb 20197:00 amRNSFarm out of licences to Shell U.K. Limited
1st Feb 20197:00 amRNSExtension to Exclusivity Agreement
28th Nov 20184:40 pmRNSSecond Price Monitoring Extn
28th Nov 20184:35 pmRNSPrice Monitoring Extension
28th Nov 20187:00 amRNSExclusivity Agreement & Licence Extensions
27th Sep 20183:34 pmRNSLicence Update on P2252 & 2248
3rd Sep 20187:00 amRNSInterim Results
30th Aug 20187:00 amRNSFormal Award of Licences
31st Jul 20185:00 pmRNSTotal Voting Rights
10th Jul 20188:47 amRNSTurner Pope Investor Evening

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.